Not a member? Sign up for free!

Looking Beyond Mood & Psychosis: A Focus On Neurocognition

Webinar | June 7, 2017 12:00 pm to 1:00 pm EST
You must be logged in to register for PsychU events. Log In

Not a member? Sign up for free!

Join us as we continue our efforts towards improving the future of mental health care through information, discussion, and collaboration.
Sign up today for instant access to all PsychU offerings. Membership is free!

Join PsychU


Virtual Forum: Looking Beyond Mood & Psychosis: A Focus On Neurocognition

Location: Online Via

Description: Historically, cognitive impairment was considered an artifact of patients' symptoms, attention, or motivation problems, and as such, was an underappreciated feature of schizophrenia. However, recent research has shown cognitive impairment to be a feature of schizophrenia, independent of delusions and hallucinations, that is stable throughout the course of the disease in a majority of patients. Cognitive impairment in bipolar disorder is also becoming an increasingly studied phenomenon - with documented demonstration of neuropsychologic impairment in some patients. Recollection memory, attention, and visual information processing may be particularly impaired in patients with bipolar illness. Additionally, cognitive impairment appears to worsen with illness progression, and may have a significant impact on function; when present, it may account in part for the poor judgment and decision making that afflicts some patients with bipolar disorder.

In this virtual forum, two neuropsychologists, Katherine Burdick, PhD and Philip D. Harvey, PhD will discuss the history, presentation, and clinical impact of cognitive impairment for both patients with schizophrenia and bipolar disorder. They will also discuss the categorical diagnostic overlap and within disorder heterogeneity cognitive impairment, as well as the relationship of each with social function.

Speakers are paid consultants for Otsuka Pharmaceutical Development & Commercialization, Inc. 

View Flyer (PDF)

Event Speakers

Philip D. Harvey, PhD
Featured Speaker

Philip D. Harvey, PhD is the Leonard M. Miller Professor of Psychiatry and Director of the Division of Psychology at the University of Miami Miller School of Medicine and a VA Senior Health Scientist.  He was formerly a Professor of Psychiatry at Emory University School of Medicine and Mt. Sinai School of Medicine.  He is the author of over 1,000 scientific papers and abstracts and he has written over 60 book chapters.  He is a widely cited author who was repeatedly designated by Thompson-Reuters as the being in the top 1% of all researchers in citations in mental health each year since 2010. He has edited 6 books and written 4 books on topics of psychological assessment, schizophrenia, and aging.  He has received a number of awards, including the Inaugural Schizophrenia International Research Society Clinical Scientist Distinguished Contributions award (2012), the 2014 Alexander Gralnick Schizophrenia Research award from the American Psychiatric Foundation, and the 2014 John Blair Barnwell award, the highest award for Clinical Research across all scientific disciplines from the US Department of Veterans affairs.

His research has focused for years on cognition and functioning and he has written extensively on aging in schizophrenia, negative symptoms in schizophrenia, functional impairments in severe mental illness, the cognitive effects of typical and atypical antipsychotics, as well as studying the effects of cognitive enhancing agents and cognitive training in various conditions, including schizophrenia, dementia, affective disorders, and traumatic brain injury.

Katherine Burdick, PhD
Featured Speaker

Dr. Katherine E. Burdick is the Director of the Mood and Psychosis program at Brigham and Women’s hospital, and Professorial Lecturer at The Icahn School of Medicine at Mount Sinai (ISMMS). She has expertise in clinical and neurocognitive assessment across a range of patients with psychotic disorders, including schizophrenia and bipolar disorder.

Dr. Burdick holds a Ph.D. in Clinical Neuropsychology from the City University of New York-The Graduate Center. She completed her clinical internship and her postdoctoral fellowship at Yale University School of Medicine and is licensed in the state of New York.

Dr. Burdick’s primary research focus is on identifying persistent cognitive deficits in major psychiatric disorders, understanding their etiologies, and directly targeting them with treatment. She has received substantial grant support for this work from the National Institute of Mental Health (NIMH), Office of Veteran’s Affairs, and private foundations.

Aneta Fornal, PharmD

Aneta Fornal, PharmD, serves as a Senior Medical Science Liaison for Otsuka Pharmaceutical Development & Commercialization, Inc. Her clinical area of expertise is medical information.

Aneta attended the Philadelphia College of Pharmacy in Philadelphia, Pennsylvania.

The registration for this event is now closed. For more information about our live event registration process, please read the Live Event Eligibility Requirements